The Affordable Care Act (ACA) is a “treasure chest of [health] policy innovations,” writes HSPH’s John McDonough in an article for the Journal of Health Politics, Policy and Law (JHPPL). These innovations are largely unknown, overlooked by greater attention to other aspects of the law. But the law’s Section 1332, “Waiver for State Innovation” (known as the “Wyden waiver” for the senator who introduced it), which will allow state governments to apply for a waiver of significant portions of the ACA, could become a “game-changer” when it is implemented in 2017 as it allows state governments to use ACA funding for alternative health reform frameworks.
Read “Wyden’s Waiver: State Innovation on Steroids” in JHPPL.
Learn more:
HSPH experts comment on the Affordable Care Act
The Supreme Court’s decision on the Affordable Care Act [podcast]